Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials

Zhiqiao Xu(Kaifeng University), Xiaojing Tie, Ning Li(Sun Yat-sen University), Ling Gao(Nanjing Medical University), Xīn Gào(Qingdao University), Yan Zhang(Qilu Hospital of Shandong University), Peijie Liu(Beijing University of Posts and Telecommunications)
BMJ Open
March 1, 2017
Cited by 64


Related Papers